Clinical trials
Phase 1 Endocrine Gland Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2022 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| Syndax Pharmaceuticals | 2 |
| National Cancer Institute (NCI) | 1 |
| Sumitomo Pharma America, Inc. | 1 |
| Tesaro, Inc. | 1 |
| University of California, Irvine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endocrine Gland Neoplasms | 9 |
| Neoplasms | 5 |
| Digestive System Neoplasms | 3 |
| Sarcoma | 3 |
| Urologic Neoplasms | 3 |
| Bone Neoplasms | 2 |
| Breast Diseases | 2 |
| Breast Neoplasms | 2 |
| Bronchial Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
Trials
Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.